TY - JOUR
T1 - Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia
AU - Ichikawa, Tomohiro
AU - Saruwatari, Koichi
AU - Mimaki, Sachiyo
AU - Sugano, Masato
AU - Aokage, Keiju
AU - Kojima, Motohiro
AU - Hishida, Tomoyuki
AU - Fujii, Satoshi
AU - Yoshida, Junji
AU - Kuwata, Takeshi
AU - Ochiai, Atsushi
AU - Suzuki, Kenji
AU - Tsuboi, Masahiro
AU - Goto, Koichi
AU - Tsuchihara, Katsuya
AU - Ishii, Genichiro
N1 - Funding Information:
This study was supported in part by National Cancer Center Research and Development Fund (25-A-6 and 28-A-9).
Publisher Copyright:
© 2017
PY - 2017/11
Y1 - 2017/11
N2 - Introduction Lung cancer mimicking organizing pneumonia (LCOP) is a novel radiological entity of lung adenocarcinoma that could be misdiagnosed as inflammatory lesions. However, the characteristic biological and genetic features of LCOP are not fully clarified. Materials and methods We used thin-section CT images to select cases of (LCOP) among surgically resected lung adenocarcinoma patients. We compared the clinicopathological characteristics and the immunophenotypes of LCOP (n = 44) and other lepidic-predominant adenocarcinomas (non-LCOP, n = 56). We also analyzed the genomic mutation features of LCOP (n = 4) by whole-exome sequencing (WES). Results All LCOP lesions were lepidic-predominant invasive adenocarcinoma. Patients with LCOP had significantly superior recurrence-free survival, compared to non-LCOP patients (95.5% and 74.4%; P = 0.006, respectively). Vascular invasion and lymph node metastasis were less frequent in LCOP than in non-LCOP patients (P = 0.001 and P = 0.03, respectively). The cancer cell expression levels of aggressiveness-related molecules, including ezrin, ALDH-1, laminin-5 were similar between LCOP and non-LCOP. On the contrary, the number of tumor promoting stromal cells, i.e., podoplanin-positive cancer-associated fibroblasts and CD204-positive tumor associated macrophages, was significantly lower in LOCP (P = 0.021 and P = 0.037, respectively). WES revealed that ABCB1, DNAH3, MSI2, and SLITRK2 were specifically mutated in LCOP. Conclusions Our results indicate that LCOP is characterized by fewer tumor-promoting stromal cells, which may contribute to the better prognosis of LCOP patients. Moreover, recognition of specific somatic mutations of LCOP patients may provide information regarding the development and progression of this type of lung cancer.
AB - Introduction Lung cancer mimicking organizing pneumonia (LCOP) is a novel radiological entity of lung adenocarcinoma that could be misdiagnosed as inflammatory lesions. However, the characteristic biological and genetic features of LCOP are not fully clarified. Materials and methods We used thin-section CT images to select cases of (LCOP) among surgically resected lung adenocarcinoma patients. We compared the clinicopathological characteristics and the immunophenotypes of LCOP (n = 44) and other lepidic-predominant adenocarcinomas (non-LCOP, n = 56). We also analyzed the genomic mutation features of LCOP (n = 4) by whole-exome sequencing (WES). Results All LCOP lesions were lepidic-predominant invasive adenocarcinoma. Patients with LCOP had significantly superior recurrence-free survival, compared to non-LCOP patients (95.5% and 74.4%; P = 0.006, respectively). Vascular invasion and lymph node metastasis were less frequent in LCOP than in non-LCOP patients (P = 0.001 and P = 0.03, respectively). The cancer cell expression levels of aggressiveness-related molecules, including ezrin, ALDH-1, laminin-5 were similar between LCOP and non-LCOP. On the contrary, the number of tumor promoting stromal cells, i.e., podoplanin-positive cancer-associated fibroblasts and CD204-positive tumor associated macrophages, was significantly lower in LOCP (P = 0.021 and P = 0.037, respectively). WES revealed that ABCB1, DNAH3, MSI2, and SLITRK2 were specifically mutated in LCOP. Conclusions Our results indicate that LCOP is characterized by fewer tumor-promoting stromal cells, which may contribute to the better prognosis of LCOP patients. Moreover, recognition of specific somatic mutations of LCOP patients may provide information regarding the development and progression of this type of lung cancer.
KW - Lung cancer
KW - Microenvironment
KW - Stromal cell
KW - Whole exome sequence
UR - http://www.scopus.com/inward/record.url?scp=85030770832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030770832&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2017.10.001
DO - 10.1016/j.lungcan.2017.10.001
M3 - Article
C2 - 29110840
AN - SCOPUS:85030770832
SN - 0169-5002
VL - 113
SP - 134
EP - 139
JO - Lung Cancer
JF - Lung Cancer
ER -